MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)

Status Completed

Clinical Trial Summary

This study will determine how if MK0782 is safe and tolerable and to determine how often and the severity of stomach and small intestine ulcers develop following administration of MK0782 plus enteric coated aspirin, rofecoxib 25mg plus enteric coated aspirin, naproxen 500 mg puls enteric coated asprin vs placebo.

This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00543868
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 2
Start date	June 2004
Completion date	August 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01435525` - Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation	N/A
Completed	`NCT00284908` - Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers	Phase 1
Completed	`NCT00952978` - Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)	Phase 3
Completed	`NCT01964131` - BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects	Phase 1
Completed	`NCT01452724` - Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer	Phase 3
Recruiting	`NCT01037491` - Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets	N/A
Completed	`NCT00595517` - Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer	Phase 3
Completed	`NCT00953381` - Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)	Phase 2
Completed	`NCT05010954` - Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer	Phase 3
Completed	`NCT01199536` - Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers	N/A
Terminated	`NCT05579444` - Systems Biology of Gastrointestinal and Related Diseases
Recruiting	`NCT03057171` - A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
Completed	`NCT01568398` - A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy	Phase 3
Terminated	`NCT00762359` - A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers	Phase 3
Completed	`NCT02423187` - Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
Completed	`NCT03553563` - A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer	Phase 3
Completed	`NCT05208268` - A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
Active, not recruiting	`NCT04702542` - To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.	N/A
Completed	`NCT00173953` - Lymphocytic Subsets and Cytokine Production With H. Pylori Infection	N/A
Completed	`NCT00132171` - Helicobacter Pylori Eradication With a New Sequential Treatment	Phase 3